CC
ADMA icon

Clearline Capital’s ADMA Biologics ADMA Stock Holding History

Clearline Capital’s Portfolio ADMA Stock Details ADMA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$5.01M Buy
+556,054
New +$8.78M 0.39% 69
2022
Q4 		– Sell
-2,496,297
Closed -$6.07M – 121
2022
Q3 		$6.07M Sell
2,496,297
-421,963
-14% -$1.01M 0.85% 37
2022
Q2 		$5.78M Sell
2,918,260
-2,219,597
-43% -$4.37M 0.81% 35
2022
Q1 		$9.4M Sell
5,137,857
-1,212,837
-19% -$1.89M 1.28% 30
2021
Q4 		$8.95M Buy
6,350,694
+5,603,249
+750% +$7.37M 1.22% 32
2021
Q3 		$845K Sell
747,445
-175,072
-19% -$245K 0.11% 107
2021
Q2 		$1.48M Buy
922,517
+574,439
+165% +$1.01M 0.22% 78
2021
Q1 		$613K Buy
+348,078
New +$797K 0.11% 85

Other funds holding ADMA

BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
N
Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $141B AUM 30.34% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return